
Mahamaya Lifesciences IPO Listing Preview: What to Expect Now?
Posted by : sachet | Fri Nov 14 2025

Click to check Mahamaya Lifesciences IPO GMP Live
The Mahamaya Lifesciences IPO will be open for bidding from 11th November to 13th November. It is a book-building issue of 2,900 crore shares. The issue is entirely a fresh issue of 9.88 crore shares. And an offer for sale of 3.48 crore shares. The IPO is expected to be listed on the BSE and NSE with a tentative listing date of 18th November 2025.
Mahamaya Lifesciences IPO Listing Preview
According to recent updates, the IPO listing of Mahamaya Lifesciences is expected to be around ₹114 per share on 18th November 2025. This conclusion is based on Mahamaya Lifesciences’s current grey market premium (GMP) for its IPO. However, the GMP and expected listing price are subject to change based on market sentiment. Stay informed with Univest to receive live updates on current IPO listings or GMP trends. Scroll to explore the GMP of the Mahamaya Lifesciences IPO.
Mahamaya Lifesciences IPO GMP Grey Market Premium
GMP is the gap between the price band of the issue and the price at which company shares ↲are currently trading in the grey market. Do you want to receive live updates on the Mahamaya Lifesciences IPO? If yes, then you’ve reached the right spot. Check the table below to learn about the GMP trends.
| GMP Date | IPO Price | GMP | Estimated Listing Price | Estimated Listing Gains |
| 14-11-2015 | ₹114.00 | ₹0 | ₹114 | 0.00% |
| 13-11-2015 | ₹114.00 | ₹0 | ₹114 | 0.00% |
| 12-11-2015 | ₹114.00 | ₹0 | ₹114 | 0.00% |
| 11-11-2025 | ₹114.00 | ₹0 | ₹114 | 0.00% |
| 10-11-2025 | ₹114.00 | ₹0 | ₹114 | 0.00% |
| 9-11-2025 | ₹114.00 | ₹0 | ₹114 | 0.00% |
| 8-11-2025 | ₹114.00 | ₹0 | ₹114 | 0.00% |
| 7-11-2025 | ₹114.00 | ₹0 | ₹114 | 0.00% |
| 6-11-2025 | ₹114.00 | ₹0 | ₹114 | 0.00% |
| 5-11-2025 | ₹114.00 | ₹0 | ₹114 | 0.00% |
As of 14th November 2025, the Mahamaya Lifesciences IPO GMP stands at ₹0 per share. This means the share will likely list at ₹114 on its tentative Listing date, 18th November 2025. GMP data is subject to change based on market conditions. Please verify the live GMP status before applying for the Mahamaya Lifesciences IPO GMP. Stay informed with Univest for real-time updates on IPOs and their GMP trends.
About Mahamaya Lifesciences Limited
Mahamaya Lifesciences Limited was established in 2007 and is engaged in the manufacturing, registration, and export of high-quality crop protection products and bioproducts for crop & soil health management, aiming to enhance productivity in the farming community. The company specialises in manufacturing pesticide formulations and supplying bulk products to Indian agrochemical companies and multinational corporations (MNCs). The company imports carefully researched molecules, registers them with the Central Insecticides Board, and markets them as technical and value-added formulations for domestic manufacturers and multinational corporations (MNCs).
- Experienced management team consisting of experts.
- Capability to introduce vital products for Indian Agriculture.
- Development of export opportunities for products.
- Ability to develop brands.
- Cordial relationships with suppliers of raw materials.
- Core values focused on achieving sustainability through innovative approaches.
Mahamaya Lifesciences Limited Financials
The company’s financial analysis is essential before applying for Mahamaya Lifesciences Limited’s IPO. Look at the table to learn about Mahamaya Lifesciences Limited’s financials.
| Year Ended | 30th June 2025 | 31st March 2025 (in cr.) | 31st March 2024 (in cr.) | 31st March 2023 (in cr.) |
| Assets | 218.87 | 188.35 | 112.07 | 77.88 |
| Revenue | 84.04 | 267.17 | 162.83 | 137.40 |
| Profit After Tax | 4.10 | 12.94 | 5.22 | 3.75 |
| EBITDA | 8.04 | 24.64 | 13.36 | 8.91 |
| Net Worth | 53.50 | 49.42 | 24.66 | 19.44 |
| Reserve and Surplus | 35.73 | 31.66 | 23.41 | 18.19 |
| Total Borrowing | 57.72 | 58.11 | 54.63 | 24.37 |
Explanation
Mahamaya Lifesciences Limited’s revenue increased by 64% from ₹162.83 crore in March 2024 to ₹267.17 crore in March 2025. Moreover, the company’s PAT increased by 148% from ₹5.22 crores to ₹12.94 crores. Investors can analyse other relevant factors and make a decision accordingly.
How to Check Mahamaya Lifesciences IPO Allotment Status?

You can check for the Mahamaya Lifesciences IPO allotment in different ways. These include BSE and the registrar portal. Follow the steps below to check your allotment status online.
Check On NSE
- Visit the BSE Official Website..
- Navigate to the IPO Allotment Section.
- Select Equity as the issue type.
- Choose the Mahamaya Lifesciences IPO.
- Choose whether to proceed with the PAN number or the application number.
- Submit your details to get the allotment status online.
Check On the Registrar Portal
- Visit the registrar portal.
- Click on the allotment option.
- Fill in the required details.
- Click on the submit button to know your Mahamaya Lifesciences IPO allotment status.
Download the Univest iOS App or the Univest Android App to get daily stock recommendations and insightful research pieces!
Recent Articles
Top 10 Penny Stocks in India | Penny Stocks to Buy in 2025
Best Stocks to Buy Today: Explore Best Stocks With Expected Trends
Milky Mist Dairy Foods IPO Details: Everything You Should Know about
Karbonsteel Engineering IPO GMP & Review: Should You Apply or Avoid?
Galaxy Medicare IPO GMP & Review: Should You Apply or Avoid?
Shringar House of Mangalsutra IPO GMP & Review: Apply or Avoid?
Dev Accelerator IPO GMP & Review: Apply or Avoid?
Sharvaya Metals India IPO Listing Preview: What to Expect Now?

